{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"submitter":["Zhang B"],"funding":["NCATS NIH HHS","NHLBI NIH HHS"],"pubmed_abstract":["<h4>Importance</h4>Post-acute sequelae of SARS-CoV-2 infection (PASC) remains a major public health challenge. While previous studies have focused on characterizing PASC and identifying its subphenotypes in children and adolescents following an initial SARS-CoV-2 infection, the risks of PASC with Omicron-variant reinfections remain unclear. Using a real-world data approach, this study investigates the risks of PASC following reinfections during the Omicron phase in the pediatric population.<h4>Objective</h4>To investigate the risks of PASC diagnosis and 24 PASC symptoms and conditions after reinfection of SARS-CoV-2 during Omicron period in the pediatric population.<h4>Design setting and participants</h4>This retrospective cohort study used data from the RECOVER consortium comprising 40 ch"],"journal":["medRxiv : the preprint server for health sciences"],"pagination":["2025.03.28.25324858"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11974971"],"repository":["biostudies-literature"],"pubmed_title":["Reinfection with SARS-CoV-2 in the Omicron Era is Associated with Increased Risk of Post-Acute Sequelae of SARS-CoV-2 Infection: A RECOVER-EHR Cohort Study."],"pmcid":["PMC11974971"],"funding_grant_id":["OT2 HL161847","UL1 TR001878"],"pubmed_authors":["Horowitz CR","Jhaveri R","Chuang CH","Liebovitz DM","Bisyuk Y","Liu M","Wu Q","Taylor BW","Zhou T","Fort D","Cowell LG","Kim S","Williams DA","Forrest CB","Suresh S","Schwenk HT","Chrischilles EA","Mosa ASM","Chen Y","Becich MJ","Ladino N","Zhang B","Blancero F","Morris JS"],"additional_accession":[]},"is_claimable":false,"name":"Reinfection with SARS-CoV-2 in the Omicron Era is Associated with Increased Risk of Post-Acute Sequelae of SARS-CoV-2 Infection: A RECOVER-EHR Cohort Study.","description":"<h4>Importance</h4>Post-acute sequelae of SARS-CoV-2 infection (PASC) remains a major public health challenge. While previous studies have focused on characterizing PASC and identifying its subphenotypes in children and adolescents following an initial SARS-CoV-2 infection, the risks of PASC with Omicron-variant reinfections remain unclear. Using a real-world data approach, this study investigates the risks of PASC following reinfections during the Omicron phase in the pediatric population.<h4>Objective</h4>To investigate the risks of PASC diagnosis and 24 PASC symptoms and conditions after reinfection of SARS-CoV-2 during Omicron period in the pediatric population.<h4>Design setting and participants</h4>This retrospective cohort study used data from the RECOVER consortium comprising 40 ch","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Mar","modification":"2026-06-06T03:24:39.729Z","creation":"2025-07-06T03:04:15.566Z"},"accession":"S-EPMC11974971","cross_references":{"pubmed":["40196285"],"doi":["10.1101/2025.03.28.25324858"]}}